Citadel Advisors’s Palvella Therapeutics, Inc. Common Stock PVLA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-10,408
Closed -$125K 7214
2024
Q4
$125K Sell
10,408
-1,278
-11% -$15.3K ﹤0.01% 5082
2024
Q3
$196K Buy
+11,686
New +$196K ﹤0.01% 4643
2024
Q2
Sell
-12,090
Closed -$177K 6989
2024
Q1
$177K Sell
12,090
-2,784
-19% -$40.8K ﹤0.01% 4848
2023
Q4
$217K Buy
14,874
+8,179
+122% +$119K ﹤0.01% 4527
2023
Q3
$160K Sell
6,695
-18,278
-73% -$436K ﹤0.01% 4643
2023
Q2
$331K Sell
24,973
-26
-0.1% -$344 ﹤0.01% 4020
2023
Q1
$1.95M Sell
24,999
-578
-2% -$45.1K ﹤0.01% 2564
2022
Q4
$2.13M Buy
25,577
+64
+0.3% +$5.33K ﹤0.01% 2517
2022
Q3
$2.35M Buy
25,513
+337
+1% +$31K ﹤0.01% 2585
2022
Q2
$3.77M Sell
25,176
-849
-3% -$127K ﹤0.01% 2140
2022
Q1
$6.31M Sell
26,025
-151
-0.6% -$36.6K ﹤0.01% 1859
2021
Q4
$7.92M Sell
26,176
-2,697
-9% -$816K ﹤0.01% 1677
2021
Q3
$11.9M Buy
28,873
+2,822
+11% +$1.17M ﹤0.01% 1280
2021
Q2
$7.98M Buy
26,051
+11,574
+80% +$3.55M ﹤0.01% 1652
2021
Q1
$2.98M Buy
14,477
+392
+3% +$80.6K ﹤0.01% 2736
2020
Q4
$2.82M Sell
14,085
-311
-2% -$62.2K ﹤0.01% 2245
2020
Q3
$2.38M Sell
14,396
-113
-0.8% -$18.7K ﹤0.01% 2119
2020
Q2
$3.6M Sell
14,509
-607
-4% -$151K ﹤0.01% 1745
2020
Q1
$2.76M Buy
15,116
+344
+2% +$62.7K ﹤0.01% 1937
2019
Q4
$4.28M Buy
14,772
+13,160
+816% +$3.81M ﹤0.01% 1740
2019
Q3
$440K Sell
1,612
-383
-19% -$105K ﹤0.01% 3553
2019
Q2
$750K Buy
1,995
+277
+16% +$104K ﹤0.01% 3209
2019
Q1
$461K Sell
1,718
-380
-18% -$102K ﹤0.01% 3437
2018
Q4
$446K Sell
2,098
-322
-13% -$68.5K ﹤0.01% 3334
2018
Q3
$1.08M Buy
2,420
+1,499
+163% +$671K ﹤0.01% 2652
2018
Q2
$373K Buy
921
+239
+35% +$96.8K ﹤0.01% 3311
2018
Q1
$372K Buy
682
+554
+433% +$302K ﹤0.01% 3118
2017
Q4
$77K Buy
+128
New +$77K ﹤0.01% 3554